Valeant Agrees to Buy Eyetech to Strengthen its Ophthalmology Business
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 2 (Table of Contents)
Published: 26 Feb-2012
DOI: 10.3833/pdr.v2012.i2.1688 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
After withdrawing an improved offer to buy ISTA Pharmaceuticals, Valeant Pharmaceuticals has entered into a definitive agreement to acquire Eyetech in order to expand its presence in the ophthalmology market...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS